Quercetin Regresses Dalton's Lymphoma Growth via Suppression of PI3K/AKT Signaling Leading to Upregulation of p53 and Decrease in Energy Metabolism

REFERENCES

• Vanhaesebroeck B, Guibert JG, Graupera M, and Bilanges B: The emerging mechanisms of isoform specific PI3K signalling. Nat Rev Mol Cell Biol 11, 329–334, 2010.
   PubMed Web of Science ®Google Scholar
• Sun ZJ, Chen G, Hu X, Zhang W, Liu Y, et al.: Activation of PI3K/Akt/IKK-α/NF-kB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin. Apoptosis 15, 850–863, 2010.
   PubMed Web of Science ®Google Scholar
• Hwang MK, Song NR, Kang NJ, Lee KW, and Lee HJ: Activation of phosphatidylinositol 3-kinase is required for tumor necrosis factor-alpha-induced upregulation of matrix metalloproteinase-9: its direct inhibition by quercetin. Int J Biochem Cell Biol 41, 1592–1600, 2009.
   PubMed Web of Science ®Google Scholar
• Geering B, Cutillas PR, Nock G, Gharbi SI, and Vanhaesebroeck B: Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers. Proc Natl Acad Sci USA 104, 7809–7814, 2007.
   PubMed Web of Science ®Google Scholar
• Hachem A and Gartenhaus RB: Oncogenes as molecular targets in lymphoma. Blood 106, 1911–1923, 2005.
   PubMed Web of Science ®Google Scholar
• Testa JR and Bellacosa A: AKT plays a central role in tumorigenesis. Proc Natl Acad Sci USA 98, 10983–10985, 2001.
   PubMed Web of Science ®Google Scholar
• Gonzalez E and McGraw TE: The Akt kinases Isoform specificity in metabolism and cancer. Cell Cycle 8, 2502–2508, 2009.
   PubMed Web of Science ®Google Scholar
• Chen WS, Xu PZ, Gottlob K, Chen ML, Sokol K, et al.: Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev 15, 2203–2208, 2001.
   PubMed Web of Science ®Google Scholar
• Cho H, Thorvaldsen JL, Chu Q, Feng F, and Birnbaum MJ: Akt1/PKB alpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 276, 38349–38352, 2001.
   PubMed Web of Science ®Google Scholar
• Moll M and Petrenko O: The MDM2–p53 Interaction. Mol Cancer Res 1, 1001–1008, 2003.
   PubMed Web of Science ®Google Scholar
• Mayo LD and Donner DB: The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. Trends Biochem Sci 9, 462–467, 2002.
   Web of Science ®Google Scholar
• Kim JW and Dang CV: Cancer's Molecular Sweet Tooth and the Warburg Effect. Cancer Res 66, 8927–8930, 2006.
   PubMed Web of Science ®Google Scholar
• Warburg O: On the origin of cancer cells. Science 123, 309–314, 1956.
   PubMed Web of Science ®Google Scholar
• Dang CV: Links between metabolism and cancer. Genes Dev 26, 877–890, 2012.
   PubMed Web of Science ®Google Scholar
• Shim H, Dolde C, Lewis BC, Wu CS, Dang CV, et al.: c-Myc transactivation of LDH-A: Implications for tumor metabolism and growth. Proc Natl Acad Sci USA 94, 6658–6663, 1997.
   PubMed Web of Science ®Google Scholar
• Neuhouser ML: Dietary flavonoids and cancer risk: evidence from human population studies. Nutr Cancer 50, 1–7, 2004.
   PubMed Web of Science ®Google Scholar
• Tang NP, Zhou B, Wang B, Yu RB, and Ma J: Flavonoids Intake and risk of lung cancer: a meta-analysis. Jpn J Clin Oncol 39, 352–359, 2009.
   PubMed Web of Science ®Google Scholar
• Cui Y, Morgenstern H, Greenland S, Tashkin DP, Mao JT, et al.: Dietary flavonoid intake and lung cancer: a population-based case-control study. Cancer 112, 2241–2248, 2008.
   PubMed Web of Science ®Google Scholar
• Gibelleni L, Pinti M, Nasi M, Montagna JP, Biasi SD, et al.: Quercetin and cancer prevention. Evid Based Complement Alternat Med 2011, 1–15, 2010.
   Web of Science ®Google Scholar
• Harwood M, Nikiel BD, Borzelleca JF, Flamm GW, Williams GM, et al.: A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol 45, 2179–2205, 2007.
   PubMed Web of Science ®Google Scholar
• Aalinkeel R, Bindukumar B, Reynolds JL, Sykes DE, Schwartz SA, et al.: The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90. Prostate 68, 1773–1789, 2008.
   PubMed Web of Science ®Google Scholar
• Soria EA, Eynard AR, Quiroga PL, and Bongiovanni GA: Differential effects of quercetin and silymarin on arseniteinduced cytotoxicity in two human breast adenocarcinoma cell lines. Life Sci 81, 1397–1402, 2007.
   PubMed Web of Science ®Google Scholar
• Lim JH, Park JW, Min DS, Chang JS, Lee YH, et al.: NAG-1 up-regulation mediated by EGR-1 and p53 is critical for quercetin-induced apoptosis in HCT116 colon carcinoma cells. Apoptosis 12, 411–421, 2007.
   PubMed Web of Science ®Google Scholar
• Neto CC, Amoroso JW: and Liberty AM: Anticancer activities of cranberry phytochemicals: an update. Mol Nutr Food Res 52, 18–27, 2008.
   PubMed Web of Science ®Google Scholar
• Kim HS, Wannatung T, Lee S, Yang WK, Chung SH, Lim JS, et al.: Quercetin enhances hypoxia-mediated apoptosis via direct inhibition of AMPK activity in HCT116 colon cancer. Apoptosis 17, 938–949, 2012.
   PubMed Web of Science ®Google Scholar
• Hirpara KV, Aggarwal P, Mukherjee AJ, Joshi N, and Burman AC: Quercetin and its derivatives: synthesis, pharmacological uses with special emphasis on anti-tumor properties and prodrug with enhanced bio-availability. Anti Canc Agents Med Chem 9, 138–161, 2009.
   PubMed Web of Science ®Google Scholar
• Mulholland PJ, Ferry DR, Anderson D, Hussain SA, Young AM, et al.: Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin. Ann Oncol 12, 245–248, 2001.
   PubMed Web of Science ®Google Scholar
• Jeong JH, An JY, Kwon YT, Rhee JG, and Lee YJ: Effects of low dose quercetin: cancer cell-specific inhibition of cell cycle progression. J Cell Biochem 106, 73–82, 2009.
   PubMed Web of Science ®Google Scholar
• Serrano ABG, Martin MA, Bravo L, Goya L, and Ramos S: Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2). J Nutr 136, 2715–2721, 2006.
   PubMed Web of Science ®Google Scholar
• Brisdelli F, Coccia C, Cinque B, Cifone MG, et al.: Induction of apoptosis by quercetin: different response of human chronic myeloid (K562) and acute lymphoblastic (HSB-2) leukemia cells. Mol Cell Biochem 296, 137–149, 2007.
   PubMed Web of Science ®Google Scholar
• Xiao X, Shi D, Liu L, Wang J, Xie X, et al.: Quercetin suppresses cyclooxygenase-2 expression and angiogenesis through inactivation of P300 signaling. Plos One 6, 1–10, 2011.
   Web of Science ®Google Scholar
• Sharma R and Vinayak M: α-Tocopherol attenuates NF-κB activation and proinflammatory cytokine IL-6 secretion in cancer bearing mice. Biosci Rep 31, 421–428, 2011.
   PubMed Web of Science ®Google Scholar
• Goldie H and Felix MD: Growth characteristics of free tumor cells transformed serially in the peritoneal fluid of the mouse. Cancer Res 11, 73–80, 1951.
   PubMed Web of Science ®Google Scholar
• Aita K, Irie H, Tanuma Y, Toida S, Okuma Y, Mori S, et al.: Apoptosis in murine lymphoid organs following intraperitoneal administration of dimethyl sulfoxide (DMSO). Exp Mol Pathol 79, 265–271, 2005.
   PubMed Web of Science ®Google Scholar
• Pathak C, Jaiswal YK, and Vinayak M: Possible involvement of queuine in regulation of cell proliferation. Biofactors 4, 159–173, 2007.
   Web of Science ®Google Scholar
• Das L and Vinayak M: Curcumin attenuates carcinogenesis by down regulating proinflammatory cytokine interleukin-1 (IL-1α and IL-1β) via modulation of AP-1 and NF-IL6 in lymphoma bearing mice. Int Immunopharmacol 20, 141–147, 2014.
   PubMed Web of Science ®Google Scholar
• Mishra S and Vinayak M: Ellagic acid induces novel and atypical pkc isoforms and promotes caspase-3 dependent apoptosis by blocking energy metabolism. Nutr Cancer 66, 675–681, 2014.
   PubMed Web of Science ®Google Scholar
• Xiao ZP, Peng ZY, Peng MJ, Yan WB, Ouyang YZ, et al.:. Flavonoids health benefits and their molecular mechanism. Mini Rev Med Chem 9, 169–177, 2011.
   Web of Science ®Google Scholar
• Nothlings U, Murphy SP, Wilkens LR, Boeing H, Schulze MB, et al.: A food pattern that is predictive of flavonol intake and risk of pancreatic cancer. Am J Clin Nutr 88, 1653–1662, 2008.
   PubMed Web of Science ®Google Scholar
• Batra P and Sharma AK: Anti-cancer potential of flavonoids: recent trends and future perspectives. Biotech 3, 439–459, 2013.
   Google Scholar
• Kelly GS: Quercetin. Altern Med Rev 16, 172–194, 2011.
   PubMedGoogle Scholar
• Ferry DR, Smith A, Malkhandi J, Fyfe DW, Detakats PG, et al.: Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res 2, 659–668, 1996.
   PubMed Web of Science ®Google Scholar
• Scheig R: Evaluation of test used to screen patients with liver disorders. Primary Care Clin Office Prac 23, 551–560, 1996.
   PubMed Web of Science ®Google Scholar
• Kato Y, Ozawa S, Miyamoto C, Maehata Y, Suzuki A, et al.: Acidic extracellular microenvironment and cancer. Cancer Cell Int 13, 1–8, 2013.
   PubMed Web of Science ®Google Scholar
• Cohen B, Yoakim M, Wormst HP, Robertst TM, Brian S, et al.: Tyrosine phosphorylation is a signal for the trafficking of pp85, an 85-kDa phosphorylated polypeptide associated with phosphatidylinositol kinase activity. Proc Natl Acad Sci USA 87, 4458–4462, 1990.
   PubMed Web of Science ®Google Scholar
• Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, et al.: Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 6, 909–919, 2000.
   PubMed Web of Science ®Google Scholar
• Priyadarsini R, Murugan RS, Maitreyi S, Ramalingam K, Karunagaran D, et al.: The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-kB inhibition. Eur J Pharmacol 649, 84–91, 2010.
   PubMed Web of Science ®Google Scholar